NBCNews.comCancer drug spending doubled in last 5 years, report saysNBCNews.comSpending on cancer drugs has doubled over the past five years, and little wonder: Every new cancer drug brought to market last year cost $100,000 or more, according to a new… Continue reading
Xconomy |
Immunotherapy Biotech Kiromic Considers San Antonio Move for Cash
Xconomy San Antonio — Kiromic, a Houston-based biotech company with artificial intelligence software that it’s using to develop two experimental cancer immunotherapies, may move to San Antonio—if it gets $200,000 from a city-operated economic development … |
Xconomy |
Immunotherapy Biotech Kiromic Considers San Antonio Move for Cash
Xconomy San Antonio — Kiromic, a Houston-based biotech company with artificial intelligence software that it’s using to develop two experimental cancer immunotherapies, may move to San Antonio—if it gets $200,000 from a city-operated economic development … |
Medscape |
Time to ‘Rethink’ Immunotherapy for Molecularly Driven NSCLC
Medscape West: One concept that we have come to an early conclusion on has been immunotherapy in patients with EGFR mutations or ALK rearrangements. Based on the early work with monotherapy in the second-line setting, we have seen that the subgroup of … |